|
Safety and tolerability of HLX07 combined with chemotherapy in patients with advanced solid tumors. |
|
|
No Relationships to Disclose |
|
|
Honoraria - BMS; Merck Serono; MSD; Roche |
Consulting or Advisory Role - Bayer; Merck Serono; MSD; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Shanghai Henlius Biotech |
|
|
Employment - Shanghai Henlius Biotech |
|
|
Employment - Shanghai Henlius Biotech |
|
|
No Relationships to Disclose |
|
|
Employment - Shanghai Henlius Biotech |
|
|
No Relationships to Disclose |